Our team has demonstrated the presence of SETDB1 abnormalities, particularly its amplification, through WES analysis of osteosarcoma human samples ...
OS Therapies, Inc. (NYSE-A: OSTX) entered into agreements for the commercial manufacture of OST-HER2. The company is ...
OS Therapies, Inc. (NYSE-A: OSTX), a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into ...
NEW YORK - OS Therapies, Inc. (NYSE-A: OSTX), a small-cap biotech firm with a market capitalization of $42 million focusing on cancer treatment solutions, has announced the completion of its Phase 2b ...
MT Newswires on MSN14h
Wall Street Set to Open Slightly Lower Friday as Retail Sales Slump More Than ExpectedUS stocks looked set to open marginally lower in Friday's trading session as retail sales in January fell far more than expected. The Dow Jones Industrial Average futures were down 0.15%, S&P 500 ...
Childhood cancer affects children under 18 and requires specialized treatment. Common types include leukemia, brain and ...
More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback